Form 8-K GeneDx Holdings Corp. For: Jul 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- AI stocks lift Wall St as oil falls, Treasury yields decline
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
- Novo Nordisk shares drop as investor event disappoints
GeneDx (WGS) PT Raised to $45 at BTIG
July 31, 2024 4:57 AM EDTBTIG analyst Mark Massaro raised the price target on GeneDx (NASDAQ: WGS) to $45.00 (from $35.00) while maintaining a Buy rating.
The analyst comments "Shares of WGS are indicating up +10% AH following another strong quarterly beat-and-raise. WGS drove a ~$10M revenue beat (~16%... More
